Azitra

company

About

Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
Alternative Medicine,Biotechnology,Consumer Goods,Health Care
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory, is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$0.94M
Azitra has raised a total of $0.94M in funding over 2 rounds. Their latest funding was raised on Apr 9, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 9, 2019 Grant $719.70K 1 National Science Foundation Detail
Aug 1, 2018 Grant $225K 2 National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Detail

Investors

Number of Lead Investors
Number of Investors
3
3
Azitra is funded by 3 investors. National Science Foundation and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
National Institutes of Health Yes Grant
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Yes Grant